Literature DB >> 22966144

National and international policies to mitigate disease threats.

Christopher Dye1.   

Abstract

To devise and implement effective health policy, we must define the problem, choose the tools, craft the policy, build consensus, set goals and deadlines, raise funds and take action. Success or failure depends on the perception of risk, the strength of the underlying science, the efficacy of the technology, ownership and intellectual property, the conflict between individual and public health, the choice of weaker (guidelines) and stronger (law) policy instruments, the level of public interest, political opportunity, institutional inertia, mechanisms for enforcement and who foots the bill. All these things considered, this paper is a brief policy-making guide by example, illustrating some achievements and disappointments with reference to cholera, drug-resistant tuberculosis, HIV/AIDS and rabies.

Entities:  

Mesh:

Year:  2012        PMID: 22966144      PMCID: PMC3427563          DOI: 10.1098/rstb.2011.0373

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  27 in total

Review 1.  The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.

Authors:  Julio S G Montaner; Robert Hogg; Evan Wood; Thomas Kerr; Mark Tyndall; Adrian R Levy; P Richard Harrigan
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

2.  Global triage of global resources needed.

Authors:  Daniel J Barnett; Saad B Omer; David P Fidler; Ran D Balicer; James G Hodge
Journal:  BMJ       Date:  2007-05-26

3.  Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-03-24       Impact factor: 17.586

4.  Public health. The cholera crisis in Africa.

Authors:  S Bhattacharya; R Black; L Bourgeois; J Clemens; A Cravioto; J L Deen; Gordon Dougan; R Glass; R F Grais; M Greco; I Gust; J Holmgren; S Kariuki; P-H Lambert; M A Liu; I Longini; G B Nair; R Norrby; G J V Nossal; P Ogra; P Sansonetti; L von Seidlein; F Songane; A-M Svennerholm; D Steele; R Walker
Journal:  Science       Date:  2009-05-15       Impact factor: 47.728

5.  A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance.

Authors:  M Loveday; L Thomson; M Chopra; Z Ndlela
Journal:  Int J Tuberc Lung Dis       Date:  2008-09       Impact factor: 2.373

6.  Revolutions in public health: 1848, and 1998?

Authors:  C Hamlin; S Sheard
Journal:  BMJ       Date:  1998-08-29

7.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

Authors:  Neel R Gandhi; Anthony Moll; A Willem Sturm; Robert Pawinski; Thiloshini Govender; Umesh Lalloo; Kimberly Zeller; Jason Andrews; Gerald Friedland
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

8.  Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

Authors:  Brian G Williams; Christopher Dye
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

9.  XDR-TB in South Africa: no time for denial or complacency.

Authors:  Jerome Amir Singh; Ross Upshur; Nesri Padayatchi
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

10.  XDR-TB in South Africa: detention is not the priority.

Authors:  Eric Goemaere; Nathan Ford; Daniel Berman; Cheryl McDermid; Rachel Cohen
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

View more
  2 in total

1.  Disease invasion: impacts on biodiversity and human health.

Authors:  Andrew A Cunningham; Andrew P Dobson; Peter J Hudson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-10-19       Impact factor: 6.237

2.  A theoretical examination of the relative importance of evolution management and drug development for managing resistance.

Authors:  Nathan S McClure; Troy Day
Journal:  Proc Biol Sci       Date:  2014-12-22       Impact factor: 5.349

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.